While previous studies have identified defects in a select few mutants, it is unclear whether they are generally common to the spectrum of DDX3X/DED1 mutations, and thus the identified phenotypes may not be key contributors to medulloblastoma pathology. This evidence concerns the gene DDX3X and medulloblastoma.